U.S. National Institutes of Health
U.S. National Institutes of Health

IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
104193104193Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis PatientsWithdrawnNo Results AvailableScleroderma, Systemic|Hypertension, Pulmonaryhttps://ClinicalTrials.gov/show/NCT01202045
104194104194Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid TumorsActive, not recruitingNo Results AvailableMetastatic Renal Cell Carcinoma|Advanced Refractory Solid Tumors Histologically or Cytologically ConfirmedDrug: Association of Bevacizumab (BVC)+ Pazopanib (PZP)https://ClinicalTrials.gov/show/NCT01202032
104195104195Effects of Exercise in People With TetraplegiaCompletedNo Results AvailableSpinal Cord Injury|TetraplegiaOther: Circuit Resistance Training (CRT)https://ClinicalTrials.gov/show/NCT01202019
104191104191A Clinical Pharmacological Study of Rabeprazole Sodium in Japanese Healthy Adult Male Volunteers (Study E3810)CompletedHas ResultsHealthyDrug: Rabeprazole sodium, 5 mg Tablets|Drug: Rabeprazole sodium, 10 mg Tablets|Drug: Rabeprazole sodium, 20 mg Tablets|Drug: Rabeprazole sodium, 40 mg Tablets (two 20 mg Tablets)https://ClinicalTrials.gov/show/NCT01202071
104196104196Strategy to Recognize and Initiate Treatment of Chronic Heart FailureCompletedNo Results AvailableHeart FailureOther: Training of general practitioners in an uptitration protocol.https://ClinicalTrials.gov/show/NCT01202006
104197104197Clinical and Laboratory Characteristics of Patients Admitted With Syncope; Diagnosis and Follow up After These PatientsSuspendedNo Results AvailableDiagnosis|Recurrencehttps://ClinicalTrials.gov/show/NCT01201993
104192104192An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II)TerminatedNo Results AvailableAtherosclerotic Coronary Artery DiseaseDevice: NEVO™ Sirolimus-eluting Coronary Stent System|Device: XIENCE V®/XIENCE PRIME™/PROMUS® Everolimus-eluting Coronary Stent System)https://ClinicalTrials.gov/show/NCT01202058
104198104198An Epidemiological Study to Evaluate Standard Daily Practice in Managing Patients With Arterial HypertensionCompletedNo Results AvailableHypertensionhttps://ClinicalTrials.gov/show/NCT01201980
104199104199A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac PatientsCompletedHas ResultsDepression|Generalized Anxiety Disorder|Panic DisorderOther: Collaborative care|Other: Usual carehttps://ClinicalTrials.gov/show/NCT01201967
104200104200Pain Relief of Newborn Preterm Infants During Endotracheal SuctioningCompletedNo Results AvailablePainDrug: sucrosehttps://ClinicalTrials.gov/show/NCT01201954
104201104201Operational Assessment of Laboratory Information System for MDR-TB in Lima, PeruCompletedNo Results AvailableTuberculosis, Multidrug-ResistantOther: e-Chasquihttps://ClinicalTrials.gov/show/NCT01201941
104202104202Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166TerminatedNo Results AvailableType 1 Diabetes Mellitus|Type 2 Diabetes MellitusDrug: Comparator administered in parent trial|Drug: Technosphere Insulin Inhalation Powderhttps://ClinicalTrials.gov/show/NCT01201928
104203104203A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell CarcinomaCompletedHas ResultsBasal Cell CarcinomaDrug: Vismodegibhttps://ClinicalTrials.gov/show/NCT01201915
104204104204A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) VaccineCompletedNo Results AvailableInfluenza InfectionBiological: Adjuvanted influenza A(H1N1) vaccine|Biological: Adjuvanted influenza A(H1N1) vaccine|Biological: un-adjuvanted influenza A(H1N1) vaccine|Biological: Adjuvanted influenza A(H1N1) vaccine|Biological: Adjuvanted influenza A(H1N1) vaccinehttps://ClinicalTrials.gov/show/NCT01201902
104205104205[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01201889
104206104206DPBRN Reasons for Replacement or Repair of Dental RestorationsCompletedNo Results AvailableDental Carieshttps://ClinicalTrials.gov/show/NCT01201876
104207104207Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone TherapyCompletedNo Results AvailableTestosterone|Trauma|Brain InjuryDrug: Androgel (Testosterone Gel)|Drug: Androgel Placebohttps://ClinicalTrials.gov/show/NCT01201863
104208104208The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System TumorsRecruitingNo Results AvailableRadiation NecrosisDrug: Bevacizumab (Avastin®)https://ClinicalTrials.gov/show/NCT01201850
104209104209Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE TrialCompletedNo Results AvailableAcute Coronary SyndromeDrug: Placebo|Drug: CER-001https://ClinicalTrials.gov/show/NCT01201837
104210104210Thoracoscopic Localization of Pulmonary Nodules Using Direct Intracavitary Thoracoscopic UltrasoundRecruitingNo Results AvailableLung CancerProcedure: intracavitary ultrasoundhttps://ClinicalTrials.gov/show/NCT01201824
104211104211Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)CompletedHas ResultsMyelodysplastic SyndromesDrug: Azacitidinehttps://ClinicalTrials.gov/show/NCT01201811
104212104212Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior UveitisCompletedHas ResultsEndogenous Anterior UveitisDrug: Difluprednate 0.05% ophthalmic emulsion|Drug: Prednisolone acetate 1.0% ophthalmic suspensionhttps://ClinicalTrials.gov/show/NCT01201798
104213104213Aspirin Dosing in Diabetic PatientsCompletedHas ResultsType 2 Diabetes Mellitus|Coronary Artery DiseaseDrug: Aspirinhttps://ClinicalTrials.gov/show/NCT01201785
104214104214Prasugrel Re-load StrategiesCompletedHas ResultsCoronary Artery DiseaseDrug: Prasugrelhttps://ClinicalTrials.gov/show/NCT01201772
104215104215Effects of Salsalate on Prandial-Induced Vascular Inflammation After Spinal Cord Injury (SCI)CompletedHas ResultsSpinal Cord InjuryDrug: Salsalate 2grams twice a day for 30 days. Then Placebo for 30 days|Drug: Placebo twice a day for 30 days. Then Salsalate 2gr BID for 30 days.https://ClinicalTrials.gov/show/NCT01201759
104216104216Influence of Periodontal Treatment on Systemic Inflammatory MediatorsCompletedNo Results AvailablePeriodontal Disease|Coronary Heart DiseaseProcedure: No treatment|Procedure: Periodontal therapyhttps://ClinicalTrials.gov/show/NCT01201746
104217104217Traditional Thai Massage and Brain Electrical ActivityCompletedNo Results AvailableScapulocostal SyndromeOther: Traditional Thai massage|Other: Ultrasound therapy and hot packhttps://ClinicalTrials.gov/show/NCT01201733
104218104218Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With "Acute-on-chronic Liver Failure"CompletedNo Results AvailableLiver Cirrhosis|Liver FailureProcedure: Plasma exchange with albuminhttps://ClinicalTrials.gov/show/NCT01201720
104219104219Evaluation of Angioplasty in the Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple SclerosisTerminatedNo Results AvailableMultiple SclerosisProcedure: Angioplasty|Other: Observationhttps://ClinicalTrials.gov/show/NCT01201707
104220104220Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)CompletedNo Results AvailableAdvanced CancersDrug: Surface-Controlled Water Soluble Curcumin|Drug: Surface-Controlled Water Soluble Curcumin MTDhttps://ClinicalTrials.gov/show/NCT01201694
Tüm Sayfalarda Arama Yap

* Görseller ve İçerik tekif hakkına sahip olabilir